Syros Pharmaceut (SYRS) Total Assets by Year
Syros Pharmaceut closed fiscal year 2023 with $168.2M in total assets, $151.5M in total liabilities and $16.7M in shareholder equity. This represents a decrease of 31.2% from the prior fiscal year. The table below carries 10 fiscal years, from 2014 to 2023, and the quarters Syros Pharmaceut has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SYRS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $168.2M-31.2% | $244.5M+33.6% | $182.9M-14.2% | $213.3M+42.2% | $150.0M+40.5% | $106.8M+36.0% | $78.5M-14.1% | $91.3M+109.3% | $43.6M | N/A |
| Total Liabilities | $151.5M+29.8% | $116.8M+19.5% | $97.7M-20.4% | $122.7M+73.3% | $70.8M+151.2% | $28.2M+114.1% | $13.2M+22.8% | $10.7M-88.3% | $91.6M | N/A |
| Total Equity | $16.7M-87.0% | $127.7M+49.9% | $85.2M-5.9% | $90.6M+14.4% | $79.2M+0.8% | $78.6M+20.3% | $65.3M-19.0% | $80.6M+268.0% | -$48.0M-120.3% | -$21.8M |
SYRS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-Q | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $85.0M-42.5% | $106.7M-41.0% | $134.7M-34.4% | $168.2M-31.2% | $147.8M-48.1% | $181.0M+43.4% | $205.3M+35.0% | $244.5M+33.6% | $284.7M+36.9% | $126.2M-46.0% | $152.1M-41.6% | $182.9M-14.2% |
| Total Liabilities | $96.1M-13.8% | $113.1M+4.9% | $119.7M+21.4% | $151.5M+29.8% | $111.5M-28.3% | $107.7M+13.2% | $98.6M+10.3% | $116.8M+19.5% | $155.6M+52.5% | $95.2M-8.2% | $89.3M-19.3% | $97.7M-20.4% |
| Total Equity | -$11.1M-130.6% | -$6.4M-108.7% | $15.1M-85.9% | $16.7M-87.0% | $36.3M-71.9% | $73.2M+136.1% | $106.8M+70.1% | $127.7M+49.9% | $129.2M+21.8% | $31.0M-76.1% | $62.7M-58.1% | $85.2M-5.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Syros Pharmaceut financials
Frequently Asked Questions
What was Syros Pharmaceut's total assets in fiscal year 2023?
Syros Pharmaceut closed fiscal year 2023 with $168.2M in total assets, $151.5M in total liabilities and $16.7M in shareholder equity.
How fast is Syros Pharmaceut's total assets growing?
Syros Pharmaceut (SYRS) total assets fell by 31.2% year over year, from $244.5M to $168.2M in fiscal year 2023.
What was Syros Pharmaceut's total assets in the most recent quarter?
Syros Pharmaceut (SYRS) reported $85.0M in total assets in Q3 2024. This represents a decrease of 42.5% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Syros Pharmaceut (SYRS) reported on that line in every period on record.